Introduction. Comorbidities increase the risk of postoperative complications in patients with benign prostatic hyperplasia (BPH).

The aim of the study was to evaluate the clinical profile of patients with BPH requiring surgery.

Materials and methods. The study included 850 patients admitted for surgical treatment for BPH. The age of the patients ranged from 45 to 94 years. A retrospective assessment was performed of age of patients, presence of complications and comorbid conditions, preoperative pharmacotherapy and indications for surgery.

Results. The mean age was 67 years. 76.7% patients had significant comorbidities. 53.6% patients were admitted with complications of BPH. The most common complication was acute urinary retention. Patients with complicated BPH were older than patients without complications. Only 450 (52.9%) patients had preoperative pharmacotherapy. In comparison with patients without complications, significantly less patients with complicated BPH received preoperative pharmacotherapy. There were no statistically significant differences in age and prostate volume between the groups of patients who received pharmacotherapy and without pharmacotherapy at the time of BPH surgery.

Conclusions. The proportion of patients with complicated forms of BPH remains high. Usually patients with BPH undergo surgery according to absolute indications. The widespread use of pharmacotherapy does not increase the age of patients, the frequency and severity of complications, and the prevalence of comorbidities at the time of surgery. Patients who receive pharmacotherapy are more likely to undergo surgery before complications occur.